Related Experiment Video
Updated: Feb 8, 2026

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse
Published on: October 26, 2017
Pre-hypertension and subclinical cardiac damage: A meta-analysis of echocardiographic studies
Cesare Cuspidi1, Carla Sala2, Marijana Tadic3
1Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy; Istituto Auxologico Italiano, Milano, Italy.
Insights
Pre-hypertension (pre-HTN) is associated with intermediate cardiac changes between normal blood pressure and hypertension. These findings indicate pre-HTN is not benign and may benefit from early preventive strategies to avoid preclinical cardiac damage.
Area of Science:
- Cardiology
- Hypertension Research
- Diagnostic Imaging
Background:
- The cardiac implications of pre-hypertension (pre-HTN) are not well-defined.
- Subclinical cardiac damage in untreated pre-HTN requires further investigation.
Purpose of the Study:
- To systematically analyze echocardiographic studies on pre-HTN.
- To comprehensively assess structural and functional cardiac changes in pre-HTN.
Main Methods:
- Systematic meta-analysis of 20 echocardiographic studies.
- Inclusion of 73,556 subjects (normotensive, pre-HTN, and hypertensive).
- Analysis of left ventricular mass, relative wall thickness, E/e' ratio, and left atrial size.
Main Results:
- Pre-HTN subjects showed increased left ventricular mass index and relative wall thickness compared to normotensives.
- Elevated E/e' ratio and left atrial diameter were observed in pre-HTN versus normotensive individuals.
- Hypertensive subjects exhibited more pronounced cardiac alterations than pre-HTN subjects.
Conclusions:
- Cardiac structural and functional alterations in pre-HTN are intermediate between normotensive and hypertensive states.
- Pre-hypertension may not be a benign condition.
- Early preventive strategies could mitigate preclinical cardiac damage in pre-HTN.
Aim:
The association between pre-hypertension (pre-HTN) and subclinical cardiac damage remains undefined. We performed a systematic meta-analysis of echocardiographic studies in order to provide a comprehensive information on structural and functional cardiac changes in untreated pre-HTN subjects.
Design:
Studies were identified by crossing the following search terms: "pre-hypertension", "high normal blood pressure" "heart" "left ventricular hypertrophy", "left ventricular function", "diastolic function", "left atrial size", "aortic root size", "echocardiography."
Results:
A total 73,556 subjects (44,170 normotensive, 17,314 pre-HTN, and 12,072 HTN individuals) of both genders were included in 20 studies. Left ventricular (LV) mass index and relative wall thickness (RWT) were greater in pre-HTN than in normotensives (standard means difference: 0.32 ± 0.07 and 0.30 ± 0.07, respectively, p < 0.001 for both). The E/e' ratio (0.26 ± 0.02, p < 0.001) and left atrium (LA) diameter were higher (0.55 ± 0.02, p < 0.001) in pre-HTN than in normotensive subjects. HTN subjects showed a greater LV mass index (0.27 ± 0.03, p < 0.001), RWT (0.23 ± 0.02, p < 0.001), increased E/e' ratio (0.38 ± 0.09, p < 0.001) as well as LA diameter (0.31 ± 0.12, p < 0.001) than pre-HTN subjects.
Conclusions:
Our meta-analysis suggests that alterations in cardiac structure and function in pre-HTN subjects are intermediate between normotensive and HTN individuals. These findings suggest that pre-HTN may not be a benign entity. If so, early preventive strategies may prevent preclinical cardiac damage.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Hypertension III: Clinical Manifestations and Diagnostic Studies
Directing Effect of Substituents: meta-Directing Groups
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hypertension I: Introduction

